Radiological imaging change in a malignant bowel obstruction patient treated with octreotide

Supportive Care in Cancer

Volumn 17, Issue 6, 2009, Pages 753-755

  Shinjo, Takuya ^a   Kagami, Ryogo ^a  

^a Kobe College   (Japan)

Author keywords

Bowel obstruction; Neoplasms; Octreotide; Palliative care

Indexed keywords

FENTANYL; OCTREOTIDE; SCOPOLAMINE BUTYL BROMIDE;

ADULT; ARTICLE; CASE REPORT; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; FLUID RETENTION; FOLLOW UP; HUMAN; HYDRATION; IMAGING; INTESTINE; INTESTINE OBSTRUCTION; MALE; PRIORITY JOURNAL; SCORING SYSTEM; WATER ABSORPTION;

ANTINEOPLASTIC AGENTS, HORMONAL; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL OBSTRUCTION; MALE; MIDDLE AGED; OCTREOTIDE; PANCREATIC NEOPLASMS; VOMITING;

EID: 67349201399     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-009-0608-4     Document Type: Article

References (13)

1. DJ Feuer KE Broadley 2000 Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer Cochrane Database Syst Rev 2 CD001219
2. FF Guiro G Bertolini JV Salas 1999 Improvement in the intestinal processes of hydroelectrolytic absorption and secretion in abdominal pathologies of surgical interest treated with SMS 201-995: experimental protocol Surg Today 29 419 430 (Pubitemid 29272566)
3. C Hogenauer B Aichbichler AC Santa J Porter J Fordtran 2002 Effect of octreotide on fluid absorption and secretion by the normal human jejunum and ileum in vivo Aliment Pharmacol Ther 16 769 777 (Pubitemid 34407525)
4. S Mercadante 1995 Diarrhea in terminally ill patients: pathophysiology and treatment J Pain Symptom Manage 10 298 309
5. S Mercadante A Casuccio S Mangione 2007 Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review J Pain Symptom Manage 33 217 223 (Pubitemid 46201883)
6. S Mercadante C Ripamonti A Casuccio E Zecca L Groff 2000 Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction Support Care Cancer 8 188 191 (Pubitemid 30183034)
7. K Mystakidou E Tsilika O Kalaidopoulou K Chondros S Georgaki L Papadimitriou 2002 Comparison of octreotide administration vs. conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double-blind, controlled clinical trial Anticancer Res 22 1187 1192
8. J Philip B Depczynski 1997 The role of total parenteral nutrition for patients with irreversible bowel obstruction secondary to gynecological malignancy J Pain Symptom Manage 13 104 111 (Pubitemid 27147326)
9. Ripamonti C (2006) Bowel obstruction. In: Textbook of palliative medicine A Hodder Arnold Publication, London, pp 588-600
10. C Ripamonti A Easson H Gerdes 2008 Management of malignant bowel obstruction Eur J Cancer 44 1105 1115
11. Ripamonti C, Mercadante S (2004) Pathophysiology and management of malignant bowel obstruction. In: Oxford textbook of palliative medicine 3rd ed. Oxford University Press, New York, pp 496-506
12. C Ripamonti S Mercadante L Groff E Zecca F De Conno A Casuccio 2000 Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective, randomized trial J Pain Symptom Manage 19 23 34 (Pubitemid 30067620)
13. Sykes N (2004) Constipation and diarrhoea In: Oxford textbook of palliative medicine 3rd ed. Oxford University Press, New York, pp 483-496